Activation of peroxisome proliferator-activated receptor (PPAR)-gamma by 15S-hydroxyeicosatrienoic acid parallels growth suppression of androgen-dependent prostatic adenocarcinoma cells

被引:25
作者
Pham, H
Banerjee, T
Nalbandian, GM
Ziboh, VA [1 ]
机构
[1] Univ Calif Davis, Sch Med, Dept Dermatol TB192, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, Dept Internal Med, Div Rheumatol & Allergy, Davis, CA 95616 USA
关键词
prostate cancer; gamma-linolenic acid; 15S-hydroxyeicosatrienoic acid; dihydrotestosterone; peroxisome proliferator-activated receptor-gamma;
D O I
10.1016/S0304-3835(02)00498-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although dietary gamma-linolenic acid (GLA) and its 15-lipoxygenase metabolite, 15S-hydroxyeicosatrienoic acid (15S-HETrE), have been reported to exert antiproliferative activities in other systems, their role in prostatic carcinogenesis is unknown. To evolve a possible mechanism for the suppressive effect on growth of prostatic cells, we incubated GLA and 15S-HETrE with androgen-dependent prostatic adenocarcinoma cells. 15S-HETrE but not GLA markedly inhibited [H-3]thymidine uptake in parallel with the upregulation of peroxisome proliferator-activated receptor-gamma expression (a growth modulating nuclear receptor). The data, taken together, suggest that dietary GLA via its in vivo metabolite 15S-HETrE could serve as an endogenous adjunct to attenuate prostatic tumorigenesis. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 30 条
[1]  
BERGSTROM S, 1964, J BIOL CHEM, V239, P4006
[2]  
BORGEAT P, 1976, J BIOL CHEM, V251, P7816
[3]   KINETIC-PARAMETERS OF 5-ALPHA-REDUCTASE ACTIVITY IN STROMA AND EPITHELIUM OF NORMAL, HYPERPLASTIC, AND CARCINOMATOUS HUMAN PROSTATES [J].
BRUCHOVSKY, N ;
RENNIE, PS ;
BATZOLD, FH ;
GOLDENBERG, SL ;
FLETCHER, T ;
MCLOUGHLIN, MG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (04) :806-816
[4]  
Butler R, 2000, CELL GROWTH DIFFER, V11, P49
[5]   THE ENDOCRINOLOGY AND DEVELOPMENTAL BIOLOGY OF THE PROSTATE [J].
CUNHA, GR ;
DONJACOUR, AA ;
COOKE, PS ;
MEE, S ;
BIGSBY, RM ;
HIGGINS, SJ ;
SUGIMURA, Y .
ENDOCRINE REVIEWS, 1987, 8 (03) :338-362
[6]  
DANIELPOUR D, 1994, CANCER RES, V54, P3413
[7]   CONTROL OF THE PEROXISOMAL BETA-OXIDATION PATHWAY BY A NOVEL FAMILY OF NUCLEAR HORMONE RECEPTORS [J].
DREYER, C ;
KREY, G ;
KELLER, H ;
GIVEL, F ;
HELFTENBEIN, G ;
WAHLI, W .
CELL, 1992, 68 (05) :879-887
[8]  
FORD LG, 1994, CANCER, V74, P2726, DOI 10.1002/1097-0142(19941101)74:9+<2726::AID-CNCR2820741823>3.0.CO
[9]  
2-S
[10]  
ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0